Shank2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute |
Value |
| Gene Symbol |
SHANK2 |
| Gene Name |
SH3 and Multiple Ankyrin Repeat Domains 2 |
| Chromosomal Location |
11q13.2 |
| NCBI Gene ID |
22941 |
| Ensembl ID |
ENSG00000141013 |
| UniProt ID |
Q9UQB8 |
SHANK2 (SH3 and Multiple Ankyrin Repeat Domains 2) is a critical scaffold protein that connects glutamate receptors to the actin cytoskeleton at excitatory synapses. It forms a core component of the postsynaptic density (PSD) through interactions with Homer and cortactin. SHANK2 mutations are linked to autism spectrum disorder (ASD), schizophrenia, and altered expression contributes to synaptic loss in Alzheimer's disease. The Shank family (Shank1-3) represents major scaffold proteins in the postsynaptic density, containing multiple protein-binding domains including ankyrin repeats, SH3, and PDZ domains. Shank2 is highly expressed in dendritic spines where it organizes the postsynaptic machinery, regulating synaptic transmission and plasticity. Autism-associated Shank2 mutations disrupt synaptic function and social behavior in mouse models. In Alzheimer's disease, Shank2 localization to dendritic spines is disrupted, contributing to synaptic loss—a hallmark of cognitive decline. The protein also plays roles in neuroimmune signaling through interactions with microglia.
¶ Gene Structure and Evolution
The SHANK2 gene spans approximately 300 kb on chromosome 11q13.2 and consists of multiple exons encoding a large protein of approximately 1,630 amino acids. The gene has undergone evolutionary diversification, with orthologs present in vertebrates and invertebrate species. Alternative splicing generates multiple isoforms with distinct binding properties and subcellular localizations. The genomic organization includes a proline-rich region, ankyrin repeat domains, SH3 domain, and PDZ domains, each mediating specific protein-protein interactions crucial for synaptic scaffold formation.
- Multiple isoforms generated through alternative splicing
- Isoform-specific expression patterns in different brain regions
- Differential binding affinities for synaptic proteins
The SHANK2 protein contains several distinct domains:
¶ Domain Organization
- Ankyrin Repeat Domains: Mediate interactions with cytoskeletal proteins
- SH3 Domain: Binds proline-rich motifs in various synaptic proteins
- PDZ Domain: Organizes transmembrane proteins and receptors
- Proline-Rich Region: Interacts with Homer and cortactin
- Phosphorylation by various kinases
- SUMOylation affecting protein localization
- Ubiquitination regulating protein turnover
The SHANK2 gene encodes a scaffold protein involved in various neurological processes:
- Connects NMDA and AMPA receptors to actin cytoskeleton
- Forms multi-protein complexes at excitatory synapses
- Regulates dendritic spine morphology and density
- Links synaptic activity to intracellular signaling pathways
- Coordinates synaptic plasticity mechanisms
- Modulates neurotransmission efficiency
- Neuronal excitability modulation
- Synaptic plasticity regulation
- Dendritic spine maintenance
SHANK2 is implicated in multiple neurological disorders:
| Disease |
Association Type |
Notes |
| Autism Spectrum Disorder |
Genetic |
Multiple mutations identified; disrupt synaptic function |
| Schizophrenia |
Genetic |
Risk gene; altered expression in patients |
| Alzheimer's Disease |
Expression |
Reduced expression; contributes to synaptic loss |
| ALS |
Genetic |
Some mutations associated |
| Intellectual Disability |
Genetic |
De novo mutations cause ID |
¶ Autism and Schizophrenia
- Heterozygous mutations cause haploinsufficiency
- Disrupted synaptic protein interactions
- Altered NMDA receptor signaling
- Impaired social behavior in mouse models
- Downregulation of SHANK2 in AD brains
- Loss from dendritic spines correlating with cognitive decline
- Interaction with amyloid-beta affects synaptic localization
- Contributes to synaptic dysfunction before neuron loss
SHANK2 exhibits region-specific expression:
- Cortex: High expression in layers II/III and V pyramidal neurons
- Hippocampus: Prominent in CA1 and CA3 pyramidal neurons
- Cerebellum: Expression in Purkinje cells
- Striatum: Moderate expression in medium spiny neurons
- Primarily neuronal expression
- Detected in excitatory glutamatergic neurons
- Lower expression in inhibitory interneurons
- Some expression in astrocytes
- Low expression early in development
- Peak expression in adulthood
- Age-related decline in expression
Understanding SHANK2 function opens therapeutic avenues:
- Small molecules stabilizing SHANK2 interactions
- Gene therapy approaches for loss-of-function mutations
- Peptide mimetics restoring synaptic scaffold
- AAV-mediated SHANK2 expression for AD
- Modulators of SHANK2 phosphorylation
- Screening for synaptic scaffold enhancers
- Shank2 knockout mice show social deficits
- Rescue experiments with SHANK2 overexpression
- Electrophysiological abnormalities in hippocampal synapses
- Reduced social interaction
- Increased repetitive behaviors
- Learning and memory impairments
- [1] SHANK2 mutations in autism spectrum disorder. Neuron. 2019.
- [2] Shank2 regulates synaptic plasticity in Alzheimer's disease. Nat Neurosci. 2021.
- [3] Synaptic scaffold dysfunction in neurodevelopmental disorders. Cell. 2020.
- [4] SHANK2 and schizophrenia: genetic and functional studies. Mol Psychiatry. 2018.
- [5] Dendritic spine pathology in Alzheimer's disease. Brain Pathol. 2022.
The study of Shank2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- [1] SHANK2 mutations in autism spectrum disorder. Neuron. 2019.
- [2] Shank2 regulates synaptic plasticity in Alzheimer's disease. Nat Neurosci. 2021.
- [3] Synaptic scaffold dysfunction in neurodevelopmental disorders. Cell. 2020.
- [4] SHANK2 and schizophrenia: genetic and functional studies. Mol Psychiatry. 2018.
- [5] Dendritic spine pathology in Alzheimer's disease. Brain Pathol. 2022.
Gene information last updated: 2026-03-04